Shushan Rana, MD
Dr. Shushan Rana sets a priority in patient care through multidisciplinary collaboration within the clinic and beyond in basic, translational, and clinical research. Dr. Rana practices at UWMC, SCCA Proton Therapy Center and the Seattle Children’s Hospital.
Patient Care Philosophy
“The effects of cancer extend beyond the physical change in patient’s health by changing the intellectual, spiritual, and emotional normalcy of the patient and their loved ones. Cancer results in a big change in one’s life from such small changes in a cluster of cells. The beauty of radiation oncology lies in using smaller atomic and subatomic structure to target these small changes in order restore health and well-being.”
Education and Training
College: Austin College, Sherman, TX 2009
Medical Education: University of Texas Health Science Center San Antonio, TX 2013
Residency: Oregon Health and Science University, Portland, OR 2018
DuRoss AN, Neufeld MJ, Rana S, Thomas CR Jr, Sun C . Integrating nanomedicine into clinical radiotherapy regimens. Adv Drug Deliv Rev. 2019 Jul 4. pii: S0169-409X(19)30083-3.
Rana S, Naik A, Pillai S, Vetto J, Pommier R, Kubicky CD. Outcomes of intraoperative radiotherapy for early-stage breast cancer: Experience from a multidisciplinary breast oncology program. Am J Surg. 2019 Jun 18. pii: S0002-9610(19)30332-0
Rana S, Espinosa-Diez C, Ruhl R, Thomas Jr CR, Anand S. Differential regulation of microRNA-15a by radiation affects angiogenesis and tumor growth via modulation of acid sphingomyelinase. BioRxIv. 2018 Pre-print.
Ruhl R, Rana S, Kelley K, Espinosa-Diez C, Hudson C, Lanciault C, Thomas Jr CR, Tsikitis VL and Anand S. microRNA-451a regulates colorectal cancer proliferation in response to radiation. BMC Cancer. 2018 May 3;18(1):517.
Kelley K, Ruhl R, Rana S, Dewey E, Espinosa C, Lanciault C, Thomas Jr CR, Hunter J, Anand S, Tsikitis VL. Understanding and Resetting Radiation Sensitivity In Rectal Cancer. Annals of Surgery. 2017 Oct; 266 (4):610-616.
Chatterjee N, Rana S, Espinosa-Diez C, Anand S. MicroRNAs in Cancer: Challenges and Opportunities in Early Detection, Disease Monitoring, and Therapeutic Agents. Current Pathobiology Reports. 2017 Mar; 5(1): 35-42.
Rana S, Maples PB, Senzer N, Nemunaitis J. Stathmin 1: a novel therapeutic target for anticancer activity. Expert Rev Anticancer Ther. 8(9):1461-70. Sep 2008